Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer.
Shao B, Liu X, Li H, Song G, Di L, Jiang H, Yan Y, Zhang R, Ran R, Zhang J, Liu Y, Wang H, Wang J.
Shao B, et al. Among authors: wang h, wang j.
Curr Oncol. 2022 Aug 25;29(9):6154-6166. doi: 10.3390/curroncol29090483.
Curr Oncol. 2022.
PMID: 36135052
Free PMC article.